Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Palonosetron manufacturers

8 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

8 products found

palonosetron

Vials, injection 0.25 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA, Canada
Unavailable markets
Peru , Vietnam
Registered in
Belgium , Germany , United Kingdom
Available for
Licensing with supply, Distribution only
MAs available in
Belgium , Germany
Comments
MAs available: DE, BE Dossier availability: Canada, Europe, United Kingdom, Latin America, Emerging Market
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 19 days

palonosetron

Injection 0.075 mg, 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #31073

This pharmaceutical company specializes in oncology and has nearly two decades of experience developing generic and specialty drugs. They focus on delivering affordable, world-class chemotherapy medications across a wide range of therapeutic areas. Their robust research and development team possesses expertise in complex drug molecule development, serving diverse markets globally. With over 35 developed generics and specialty drugs, they have filed over 40 dossiers across 25 countries in emerging markets. The company is committed to expanding its presence in the oncology therapeutic area within emerging markets.

Manufacturer usually replies in 48 days

palonosetron

Vials, injection 0.05 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #10323
This company is a global manufacturer of essential lifesaving medicaments, specializing in high-tech parenteral and oral formulations. Established in 1984, it has grown from a small family business to a multinational corporation with over 2000 employees across 70 markets. Their expertise spans various therapeutic areas including anaesthesiology, critical care, pain management, gynaecology, ophthalmology, orthopaedics, oncology, and dermatology. They offer a diverse product portfolio of over 500 products, including injectables, infusions, and other dosage forms. The company prides itself on its commitment to quality, innovation, ethics, and transparency. They maintain GMP certifications and hold patents for several products. Their manufacturing sites are strategically located across key regions like the EU and North America.

Manufacturer usually replies in 13 days

Want to see all 8 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

PALONOSETRON

Palonosetron is a 5-HT3 antagonist, an antinauseant and antiemetic agent. It is used to prevent vomiting and nausea in patients who are on chemotherapy for moderately-emetogenic cancer and for preventing postoperative nausea and vomiting. Palonosetron is specific and selective serotonin 5-HT3 receptor antagonist that is related to other 5-HT3 receptor antagonists, except for structural difference.

Palonosetron is used in intensive care medicine like pneumonia & peritonitis, some diabetes-related foot infections, and as therapy for febrile neutropenia post-chemotherapy. Prolonged infusions can maximize the duration that serum concentration is maintained at a minimum inhibitory concentration of the bacteria causing the infection. As a post-chemotherapy drug, it is given to prevent nausea and vomiting which may occur within 24 hours post-chemotherapy or surgery. It also prevents delayed nausea and vomiting that may occur several days after receiving certain chemotherapies.

Palonosetron is sold under the brand names such as Aloxi Tazocin and Zosyn among others. Helsinn Healthcare SA developed Palonosetron and was approved for this use by the U.S. Food and Drug Administration. It is the most recent 5-HT3 antagonist to enter clinical use and the only drug of its class.

Dosage Forms & Strengths:

Palonosetron is available as an injectable solution in single-use vials of 0.05mg/mL concentrations. For preventing acute Nausea and Vomiting associated with moderately or highly emetogenic chemotherapeutics and for delayed N/V agents, the dose is 0.25 mg, given through IV over 30 seconds, 30 minutes before chemotherapy begins. And for prevention of Postoperative Nausea & Vomiting, the dose is 0.075 mg, administered through an IV infused over 10 seconds immediately before anaesthesia is given.

The price of Palonosetron:

In the USA, the consumers have to pay around $72 for a supply of 2 millilitres of intravenous solution with 0.25 mg of drug in the 2 mL solution. The price for the same supply is significantly cheaper in countries like India, where it costs only USD2.

How does Palonosetron work?

Palonosetron’s actions block serotonin. Serotonin causes vomiting. Palonosetron has a strong binding affinity as 5-HT3 receptor antagonist and little or no affinity for any other receptors. Cancer chemotherapy sees a high incidence of nausea and vomiting, particularly when agents, such as cisplatin, are used.

Finding Palonosetron Manufacturers and Suppliers

The best way to find and gain access to Palonosetron manufacturers and Palonosetron suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Palonosetron can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Palonosetron to work with. You can fine-tune your search results using various filters too, letting you search for Palonosetron from specific countries.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible